FDA To Include Additional FOIA Exemptions In Public Information Regs
This article was originally published in The Pink Sheet Daily
The agency will incorporate existing Freedom of Information Act exemptions related to classified information, internal personnel records and nondisclosure provisions. The direct final rule will become effective unless the agency receives adverse comments.
You may also be interested in...
The agency withdraws a direct final rule that would have implemented Freedom of Information Act exemptions relating to classified information, internal personnel rules and practices, and nondisclosure provisions after receiving two adverse comments.
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.